Contact and place of performance
Veronica B. Dillard
Washington, DC 20422
USA
The Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study. Advanced prostate cancer remains a leading cause of cancer morbidity and mortality among Veterans, yet validated circulating biomarkers that predict treatment response or early disease progression are lacking. Current clinical decision-making relies primarily on PSA kinetics and ra...
View moreThe Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study focused on advanced prostate cancer. The goal of this research is to generate reproducible, high-quality proteomic data from longitudinal plasma specimens to address the lack of validated circulating biomarkers for predicting treatment response or early disease progression. The study team intends to perform exploratory analyses linking proteomic changes to clinical outcomes, supporting future biomarker validation and precision oncology strategies for Veterans.
This Sources Sought notice, identified by solicitation number 36C24526Q0481, is issued by the Department of Veterans Affairs. The requirement is classified under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services; Health Care Services; Basic Research. There is currently no set-aside designated for this opportunity.
Performance will take place in Washington, DC, under the supervision of the contracting point of contact, Veronica B. Dillard. The notice was published on May 1, 2026, and includes two attachments: a primary solicitation document and a Statement of Work. Responses to this notice are due by May 15, 2026.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.